New Delhi, June 27 -- Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.

The report highlighted that Big Pharma companies are increasingly diversifying their manufacturing and research operations geographically, and Indian companies with expertise in small molecule development are well placed to benefit.

It said "Big Pharma is diversifying geographically, benefiting Indian CRDMOs with small molecule expertise".

The report highlighted some major pharma companies (Including Piramal Pharma, Syngene, Laurus Labs, Cohance, Gland Pharma).

The report said that these companies highlighted that many of the...